The activity of amidophosphoribosyltransferase (ATASE), a rate-limiting enzyme of the first step of the de novo pathway that catalyzes the PRPP to IMP conversion, was elevated 2-fold in CRC tumors compared to normal tissue controls. Here, PPAT is linked to colorectal carcinoma.